HSR20-098: A Systematic Literature Review of First-Line (1L) Treatments for Patients With MGMT (O-6-Methylguanine-DNA Methyl Transferase) Methylated and Unmethylated Glioblastoma Multiforme (GBM)

Authors:
Gautamjeet Singh Mangat Parexel Access Consulting, Parexel International, Mohali, Punjab, India

Search for other papers by Gautamjeet Singh Mangat in
Current site
Google Scholar
PubMed Close
 Masters in Pharmacology
,
Roelien Postema Bristol-Myers Squibb, Uxbridge, London, United Kingdom

Search for other papers by Roelien Postema in
Current site
Google Scholar
PubMed Close
 PharmD
,
Shweta Takyar Parexel Access Consulting, Parexel International, Mohali, Punjab, India

Search for other papers by Shweta Takyar in
Current site
Google Scholar
PubMed Close
 Masters in Pharmaceutics
,
Anagha Gogate Bristol-Myers Squibb, Lawrenceville, New Jersey
University of North Carolina, Chapel Hill, North Carolina

Search for other papers by Anagha Gogate in
Current site
Google Scholar
PubMed Close
 Master of Health Science, Health Economics
, and
Alex Z. Fu Bristol-Myers Squibb, Lawrenceville, New Jersey
Georgetown University Medical Center, Washington, DC

Search for other papers by Alex Z. Fu in
Current site
Google Scholar
PubMed Close
 PhD
Volume/Issue:
Volume 18: Issue 3.5
Online Publication Date:
20 Mar 2020
DOI:
https://doi.org/10.6004/jnccn.2019.7447
Restricted access

Corresponding Author: Gautamjeet Singh Mangat, MS
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2020 by the National Comprehensive Cancer Network 2020
Article Category:
Abstract
Print Publication Date:
20 Mar 2020
Online Publication Date:
20 Mar 2020

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 927 396 28
PDF Downloads 301 0 0
EPUB Downloads 0 0 0